I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Scott Schliebner is a seasoned biopharmaceutical executive with nearly 30 years of experience spanning biotech, CROs, and nonprofit life sciences organizations.

He currently serves as CEO and Founder of Assent Biostrategies.

Throughout his career, Scott has built and led high‑impact teams across drug development, commercial strategy, and patient‑centric innovation. His leadership includes senior roles such as Chief Commercial Officer for early‑stage biopharma service organizations and Senior Vice President at TFS HealthScience, where he oversaw clinical development services and contributed to corporate strategy and acquisition due diligence.

Scott is widely recognized as a patient advocate and strategic thinker who helps biotech companies accelerate their pipelines and design development programs that meaningfully incorporate patient needs.